What does “Novolog 7030” mean?
“Novolog 7030” is commonly shorthand used online for an insulin regimen described as a “70/30” mix—meaning 70% intermediate-acting insulin and 30% rapid-acting insulin—often discussed by people comparing premixed insulin options.
Novolog itself is not sold as a 70/30 premix product. Novolog (insulin aspart) is a rapid-acting insulin, and its “70/30” label usually refers to a mix with intermediate-acting insulin (rather than Novolog alone). The exact products and concentrations can vary depending on what a person is trying to describe (for example, whether they mean a specific premixed insulin product or a mixed dosing plan).
Is there an official Novolog 70/30 (7030) product?
Novolog is rapid-acting insulin aspart, so an “official Novolog 70/30” product is not how Novolog is typically marketed. If someone says “Novolog 7030,” they may be:
- Referring to a premixed insulin that is a 70/30 formulation (which would generally be a different product than Novolog alone), or
- Referring to a custom mix prescribed by a clinician, or
- Using nonstandard shorthand for their regimen.
To confirm whether “7030” matches a real, packaged product, you’d need the exact product name on the box or prescription label (and the insulin type: rapid-acting vs intermediate-acting).
How is a 70/30 insulin regimen different from using Novolog alone?
A 70/30 style regimen typically aims to cover both:
- A rapid onset (to cover mealtime glucose), and
- A longer duration (to cover between-meal glucose)
Because Novolog is rapid-acting when used alone, it is usually dosed more tightly around meals, while premixed 70/30 products often have a longer baseline effect that can reduce the need for separate intermediate insulin dosing.
People choosing between:
- “Novolog only” (rapid-acting, meal-focused) and
- A 70/30 premix (mixed coverage, more fixed timing)
often do so based on lifestyle, meal regularity, and hypoglycemia risk.
What should you check to avoid dosing mistakes?
If “Novolog 7030” is on your medication list or prescription notes, the safest next step is to verify:
- The full insulin name (not just the “7030” shorthand)
- Whether it’s actually a premixed product
- The insulin concentration and dosing instructions on your label
- Whether you’re supposed to mix insulins yourself (only do this if specifically instructed by your prescriber and with the exact product types and ratios)
Mixing up “Novolog” with a premixed 70/30 product (or using the wrong concentration) can change insulin timing and increase the risk of low blood sugar.
Can “7030” be a concentration, dose, or something else?
Yes. People sometimes use “7030” to mean different things depending on context, such as:
- A “70/30” split between two insulins
- A titration or dosing pattern written in shorthand
- A note from a prior regimen that got copied into records
The only reliable way to decode it is the exact prescription wording (or a photo of the label, if you can share it).
Quick next step
If you tell me the exact wording from the prescription label (for example, the full insulin name(s), whether it says “70/30,” and how it’s dosed), I can help interpret what “Novolog 7030” likely refers to and how it usually differs from Novolog alone.